The activation of NF-kB maintains persistent neuroinflammation in the GBM microenvironment through the expression of proinflammatory cytokines such as IL-6, IL-1β, and TNF-α, as well as chemokines (CCL2, CCL5, CXCL1) [170]. This evidence concerns the gene CCL2 and glioblastoma.